SRP-6004
SRP-6004-102
Phase 1 gene_therapy terminated
Quick answer
SRP-6004 for Limb Girdle Muscular Dystrophy is a Phase 1 program (gene_therapy) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sarepta Therapeutics
- Indication
- Limb Girdle Muscular Dystrophy
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- terminated